Issue 21, 2023

A dual-amplified ROS-responsive nanosystem with self-accelerating drug release for synergistic chemotherapy

Abstract

In this work, we have developed a tumor-specific self-accelerating prodrug activation nanosystem consisting of self-amplifying degradable polyprodrug PEG-TA-CA-DOX and encapsulated fluorescent prodrug BCyNH2, equipped with a reactive oxygen species dual-cycle amplification effect. Furthermore, activated CyNH2 is a therapeutic agent with potential to synergistically improve chemotherapy.

Graphical abstract: A dual-amplified ROS-responsive nanosystem with self-accelerating drug release for synergistic chemotherapy

Supplementary files

Article information

Article type
Communication
Submitted
04 Jan 2023
Accepted
09 Feb 2023
First published
22 Feb 2023

Chem. Commun., 2023,59, 3142-3145

A dual-amplified ROS-responsive nanosystem with self-accelerating drug release for synergistic chemotherapy

J. Li, Q. Zong, Z. Zhao and Y. Yuan, Chem. Commun., 2023, 59, 3142 DOI: 10.1039/D3CC00052D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements